Binding of polyunsaturated fatty acids to LXRα and modulation of SREBP‐1 interaction with a specific SCD1 promoter element. (29th September 2014)

• Record Type: Journal Article
• Authors: Caputo, Mariella; De Rosa, Maria Caterina; Rescigno, Tania; Zirpoli, Hylde; Vassallo, Antonio; De Tommasi, Nunziatina; Torino, Gaetano; Tecce, Mario Felice
• Is Part Of: Cell biochemistry and function. Volume 32:Number 8(2013:Dec.)
• Page Start: 637
• Page End: 646
• Publication Date: 2014-09-29
• Subjects: Cytochemistry -- Periodicals; Cell metabolism -- Periodicals; Biochemistry -- Periodicals; Cytology -- Periodicals; 572
• DOI: 10.1002/cbf.3067
• Languages: English
• ISSNs: 0263-6484

Abstract

<abstract abstract-type="main"> <title> <x xml:space="preserve">Abstract</x> </title> <p>Stearoyl‐CoA desaturase 1 (SCD1) is the rate limiting enzyme in unsaturated fatty acid biosynthesis. This enzyme has an important role in the regulation of hepatic lipogenesis and lipid oxidation, and alterations in these pathways may lead to several diseases. We examined, in HepG2 cell cultures, the mechanism of SCD1 regulation considering the involvement of two transcription factors: liver X receptor alpha (LXR<italic>α</italic>) and sterol regulatory element‐binding protein‐1 (SREBP‐1), also investigating the effect of dietary polyunsaturated fatty acids (PUFAs) on this process. The analysis of SCD1 promoter allowed to identify a functional SREBP‐1 binding site (SRE 1). LXR<italic>α</italic> activation increased SCD1 protein level through upregulation of SREBP‐1 and its consequent binding to SRE 1 sequence. Polyunsaturated docosahexaenoic acid (DHA, C22:6), eicosapentaenoic acid (EPA, C20:5) and arachidonic acid (AA, C20:4) were able to reduce SREBP‐1 binding to SCD1 promoter, while saturated stearic acid (SA, C18:0) did not give any effect. Surface plasmon resonance analysis showed a direct binding of DHA, EPA and AA to LXR<italic>α</italic>. These data indicate a direct inhibitory interaction of PUFAs with LXR<italic>α</italic>, a consequent reduction of SREBP‐1 and of its binding to SCD1 promoter. This information provides a mechanism to explain the regulation of lipogenic pathways induced by PUFAs. Copyright © 2014 John Wiley & Sons, Ltd.</p> </abstract>